VEGFA and triple-negative breast carcinoma: It was shown that EGCG inhibits the cell growth, migration and invasion in Hs578T triple negative breast cancer cells by repressing the expression of VEGF (vascular endothelial growth factor) pro-angiogenic factor [44,45].